Publication | Closed Access

Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial

OncologyMetronomic TherapyNasopharyngeal CancerFirst-line TreatmentCancer TreatmentMedicineRadiation OncologyCancer ResearchPhase 3Advanced Nasopharyngeal Carcinoma